Cytokinetics, Inc. (CYTK)

[Solantey]

I own 12,000 shares at $4.51. I am content to hold them. Tuesday's conference call should offer some indication of the opportunities that lay ahead. I have no intention of selling here.

I believe that in six months or sooner the share price will be substantially higher. I think there is substantially more upside here than downside.

Fortunately I had no position in the stock when it took the major hit last week.

Good luck to you with whatever decision you make.